158 related articles for article (PubMed ID: 10756595)
1. [Pharmacokinetic effects of antibiotics on the development of bacterial resistance particularly in reference to azithromycin].
Wenisch C
Wien Med Wochenschr; 2000; 150(3):37-41. PubMed ID: 10756595
[TBL] [Abstract][Full Text] [Related]
2. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ
Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955
[TBL] [Abstract][Full Text] [Related]
3. Correlation of in vitro activity and pharmacokinetic parameters with effect in vivo for antibiotics. Observations from experimental pneumococcus infection.
Frimodt-Møller N
Dan Med Bull; 1988 Oct; 35(5):422-37. PubMed ID: 3066588
[TBL] [Abstract][Full Text] [Related]
4. Role of pharmacokinetics and pharmacodynamics: does the dose matter?
MacGowan AP
Clin Infect Dis; 2001 Sep; 33 Suppl 3():S238-9. PubMed ID: 11524725
[TBL] [Abstract][Full Text] [Related]
5. Choosing an antibiotic on the basis of pharmacodynamics.
Craig WA
Ear Nose Throat J; 1998 Jun; 77(6 Suppl):7-11; discussion 11-2. PubMed ID: 9674328
[TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamic activity of azithromycin against macrolide-susceptible and -resistant Streptococcus pneumoniae simulating clinically achievable free serum, epithelial lining fluid and middle ear fluid concentrations.
Zhanel GG; DeCorby M; Noreddin A; Mendoza C; Cumming A; Nichol K; Wierzbowski A; Hoban DJ
J Antimicrob Chemother; 2003 Jul; 52(1):83-8. PubMed ID: 12775677
[TBL] [Abstract][Full Text] [Related]
7. Selecting antibiotics based on pharmacokinetic and pharmacodynamic principles.
Klutman NE
Pharm Pract Manag Q; 1996 Jul; 16(2):9-12. PubMed ID: 10161616
[TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamics: relation to antimicrobial resistance.
Rybak MJ
Am J Infect Control; 2006 Jun; 34(5 Suppl 1):S38-45; discussion S64-73. PubMed ID: 16813981
[TBL] [Abstract][Full Text] [Related]
9. Macrolides: pharmacokinetics and pharmacodynamics.
Van Bambeke F; Tulkens PM
Int J Antimicrob Agents; 2001; 18 Suppl 1():S17-23. PubMed ID: 11574190
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine.
McKellar QA; Sanchez Bruni SF; Jones DG
J Vet Pharmacol Ther; 2004 Dec; 27(6):503-14. PubMed ID: 15601444
[TBL] [Abstract][Full Text] [Related]
11. New dosing strategies for antibacterial agents in the neonate.
de Hoog M; Mouton JW; van den Anker JN
Semin Fetal Neonatal Med; 2005 Apr; 10(2):185-94. PubMed ID: 15701583
[TBL] [Abstract][Full Text] [Related]
12. Future in vitro and animal studies: development of pharmacokinetic and pharmacodynamic efficacy predictors for tissue-based antibiotics.
Nightingale CH
Pharmacotherapy; 2005 Dec; 25(12 Pt 2):146S-149S. PubMed ID: 16305285
[TBL] [Abstract][Full Text] [Related]
13. Duration of antibiotic treatment in surgical infections of the abdomen. Pharmacokinetic basis for short courses of antimicrobial therapy.
Wittmann DH
Eur J Surg Suppl; 1996; (576):19-23. PubMed ID: 8908464
[TBL] [Abstract][Full Text] [Related]
14. [An example of simulation for a better understanding of PK/PD relationship of antibiotics].
Le Normand Y; Ganiere-Monteil C; Drugeon H; Abbas S; Mazeas M; Kergueris MF
Pathol Biol (Paris); 2004 Dec; 52(10):597-601. PubMed ID: 15596309
[TBL] [Abstract][Full Text] [Related]
15. Optimal antibiotic dosing. The pharmacokinetic-pharmacodynamic interface.
Reed MD
Postgrad Med; 2000 Dec; 108(7 Suppl Contemporaty):17-24. PubMed ID: 19667545
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamics of doxycycline for chemoprophylaxis of Lyme disease: preliminary findings and possible implications for other antimicrobials.
Lee J; Wormser GP
Int J Antimicrob Agents; 2008 Mar; 31(3):235-9. PubMed ID: 18226504
[TBL] [Abstract][Full Text] [Related]
17. Application of pharmacokinetics and pharmacodynamics to antimicrobial therapy of respiratory tract infections.
Andes D; Anon J; Jacobs MR; Craig WA
Clin Lab Med; 2004 Jun; 24(2):477-502. PubMed ID: 15177850
[TBL] [Abstract][Full Text] [Related]
18. Relationship of minimal inhibitory concentration and bactericidal activity to efficacy of antibiotics for treatment of ventilator-associated pneumonia.
Kiem S; Schentag JJ
Semin Respir Crit Care Med; 2006 Feb; 27(1):51-67. PubMed ID: 16508882
[TBL] [Abstract][Full Text] [Related]
19. Does the dose matter?
Craig WA
Clin Infect Dis; 2001 Sep; 33 Suppl 3():S233-7. PubMed ID: 11524724
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic exposure as a risk factor for emergence of resistance: the influence of concentration.
Gould IM; MacKenzie FM
Symp Ser Soc Appl Microbiol; 2002; (31):78S-84S. PubMed ID: 12481832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
